IL111021A0 - Factor derived from muscle cells - Google Patents

Factor derived from muscle cells

Info

Publication number
IL111021A0
IL111021A0 IL11102194A IL11102194A IL111021A0 IL 111021 A0 IL111021 A0 IL 111021A0 IL 11102194 A IL11102194 A IL 11102194A IL 11102194 A IL11102194 A IL 11102194A IL 111021 A0 IL111021 A0 IL 111021A0
Authority
IL
Israel
Prior art keywords
substance
cells
cancer
muscle cells
proliferation
Prior art date
Application number
IL11102194A
Other languages
English (en)
Original Assignee
Mor Research Applic Ltd
Univ Bar Ilan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mor Research Applic Ltd, Univ Bar Ilan filed Critical Mor Research Applic Ltd
Priority to IL11102194A priority Critical patent/IL111021A0/xx
Publication of IL111021A0 publication Critical patent/IL111021A0/xx
Priority to US08/531,783 priority patent/US5962331A/en
Priority to MX9702174A priority patent/MX9702174A/es
Priority to PCT/US1995/012093 priority patent/WO1996009060A1/en
Priority to AU36816/95A priority patent/AU692931B2/en
Priority to KR1019970701853A priority patent/KR100392996B1/ko
Priority to CNB951963368A priority patent/CN1146432C/zh
Priority to AT95934498T priority patent/ATE214934T1/de
Priority to EP95934498A priority patent/EP0782452B1/en
Priority to BR9509154A priority patent/BR9509154A/pt
Priority to RU97106333/13A priority patent/RU2199327C2/ru
Priority to IL11541595A priority patent/IL115415A/en
Priority to DE69526096T priority patent/DE69526096T2/de
Priority to DK95934498T priority patent/DK0782452T3/da
Priority to CA002198727A priority patent/CA2198727C/en
Priority to JP51109996A priority patent/JP3778366B2/ja
Priority to ES95934498T priority patent/ES2174963T3/es
Priority to FI971190A priority patent/FI113153B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Sorption Type Refrigeration Machines (AREA)
IL11102194A 1994-09-22 1994-09-22 Factor derived from muscle cells IL111021A0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
IL11102194A IL111021A0 (en) 1994-09-22 1994-09-22 Factor derived from muscle cells
US08/531,783 US5962331A (en) 1994-09-22 1995-09-21 Cell growth regulator
ES95934498T ES2174963T3 (es) 1994-09-22 1995-09-22 Regulador del crecimiento celular.
EP95934498A EP0782452B1 (en) 1994-09-22 1995-09-22 Cell growth regulator
BR9509154A BR9509154A (pt) 1994-09-22 1995-09-22 Regulador de crescimento celular processos para o tratamento ou a prevenção de uma doença ou um distúrbio para a diagnose de um estado canceroso de um individuo ou para a determinação do risco de um indivíduo desenvolver câncer para a preparação de regulador de crescimento celular e composição
AU36816/95A AU692931B2 (en) 1994-09-22 1995-09-22 Cell growth regulator
KR1019970701853A KR100392996B1 (ko) 1994-09-22 1995-09-22 세포성장조절제
CNB951963368A CN1146432C (zh) 1994-09-22 1995-09-22 细胞生长调节因子
AT95934498T ATE214934T1 (de) 1994-09-22 1995-09-22 Wachstumsregulator
MX9702174A MX9702174A (es) 1994-09-22 1995-09-22 Regulador del crecimiento celular.
PCT/US1995/012093 WO1996009060A1 (en) 1994-09-22 1995-09-22 Cell growth regulator
RU97106333/13A RU2199327C2 (ru) 1994-09-22 1995-09-22 Очищенный регулятор роста клеток, способ его получения (варианты), способ лечения, профилактики и диагностики рака, состав для ингибирования роста клеток
IL11541595A IL115415A (en) 1994-09-22 1995-09-22 Low molecular weight growth factor, found in white blood cells and muscle cells endogenously, preparations containing it, processes for its acceptance and its various uses
DE69526096T DE69526096T2 (de) 1994-09-22 1995-09-22 Wachstumsregulator
DK95934498T DK0782452T3 (da) 1994-09-22 1995-09-22 Cellevækstregulator
CA002198727A CA2198727C (en) 1994-09-22 1995-09-22 Cell growth regulator
JP51109996A JP3778366B2 (ja) 1994-09-22 1995-09-22 細胞成長調節因子
FI971190A FI113153B (fi) 1994-09-22 1997-03-21 Solukasvunsäätelijä

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11102194A IL111021A0 (en) 1994-09-22 1994-09-22 Factor derived from muscle cells

Publications (1)

Publication Number Publication Date
IL111021A0 true IL111021A0 (en) 1994-11-28

Family

ID=11066570

Family Applications (2)

Application Number Title Priority Date Filing Date
IL11102194A IL111021A0 (en) 1994-09-22 1994-09-22 Factor derived from muscle cells
IL11541595A IL115415A (en) 1994-09-22 1995-09-22 Low molecular weight growth factor, found in white blood cells and muscle cells endogenously, preparations containing it, processes for its acceptance and its various uses

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL11541595A IL115415A (en) 1994-09-22 1995-09-22 Low molecular weight growth factor, found in white blood cells and muscle cells endogenously, preparations containing it, processes for its acceptance and its various uses

Country Status (17)

Country Link
US (1) US5962331A (xx)
EP (1) EP0782452B1 (xx)
JP (1) JP3778366B2 (xx)
KR (1) KR100392996B1 (xx)
CN (1) CN1146432C (xx)
AT (1) ATE214934T1 (xx)
AU (1) AU692931B2 (xx)
BR (1) BR9509154A (xx)
CA (1) CA2198727C (xx)
DE (1) DE69526096T2 (xx)
DK (1) DK0782452T3 (xx)
ES (1) ES2174963T3 (xx)
FI (1) FI113153B (xx)
IL (2) IL111021A0 (xx)
MX (1) MX9702174A (xx)
RU (1) RU2199327C2 (xx)
WO (1) WO1996009060A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4328897A (en) * 1996-08-23 1998-03-06 Board Of Regents, The University Of Texas System Anti-proliferative factor from transfected cells
IL131096A (en) * 1999-07-26 2004-09-27 Can Fite Technologies Ltd Method for preparing a composition derived from muscle tissue
US20030143282A1 (en) * 2002-01-28 2003-07-31 Pnina Fishman Adenosine A3 receptor agonist
PL2764351T3 (pl) * 2011-09-29 2019-05-31 Seattle Genetics Inc Oznaczanie nienaruszonej masy związków środków sprzężonych z białkami

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708948A (en) * 1984-04-20 1987-11-24 The United States Of America As Represented By The Department Of Health And Human Services Substantially purified tumor growth inhibitory factor
US5242692A (en) * 1990-07-10 1993-09-07 Bar Ilan University Anti-metastatic factor

Also Published As

Publication number Publication date
EP0782452B1 (en) 2002-03-27
RU2199327C2 (ru) 2003-02-27
CN1164190A (zh) 1997-11-05
DE69526096T2 (de) 2002-09-26
DE69526096D1 (de) 2002-05-02
FI971190A (fi) 1997-03-21
US5962331A (en) 1999-10-05
AU692931B2 (en) 1998-06-18
CN1146432C (zh) 2004-04-21
FI113153B (fi) 2004-03-15
AU3681695A (en) 1996-04-09
CA2198727A1 (en) 1996-03-28
DK0782452T3 (da) 2002-07-01
ES2174963T3 (es) 2002-11-16
ATE214934T1 (de) 2002-04-15
JP3778366B2 (ja) 2006-05-24
IL115415A0 (en) 1995-12-31
EP0782452A1 (en) 1997-07-09
JPH10509028A (ja) 1998-09-08
FI971190A0 (fi) 1997-03-21
WO1996009060A1 (en) 1996-03-28
IL115415A (en) 2001-05-20
CA2198727C (en) 2007-03-27
MX9702174A (es) 1998-04-30
KR100392996B1 (ko) 2003-11-28
BR9509154A (pt) 1997-10-14

Similar Documents

Publication Publication Date Title
DE3376625D1 (en) Physiological implantable cardiac pacemaker in which the stimulation rate is regulated by the respiration rate of the patient
AU2912895A (en) Implanted device containing tumor cells for the treatment of cancer
ES8203599A1 (es) Un aparato terapeutico para uso en crioterapia
DE3777253D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
PT1391215E (pt) Sistema de infusão automatizado com calculador de taxa de doseamento
TR200101225T2 (tr) Brakiterapi için ürünler ve yöntemler.
DE69920885D1 (en) C-myc-bindendes protein "c-myc coding region determinant-binding protein (crd-bp)"
DE3778585D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
IL115415A0 (en) Factor derived from muscle cells
GR3021876T3 (en) Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours.
GR3006236T3 (xx)
GB2160892B (en) Fe-cr-al type implant alloy for medical treatment
GR3001850T3 (en) Expellants of phytopathogenic microbes
EP0151385A3 (en) Use of phytosterolglycosides for the treatment of elevated 5(6) alpha-epoxycholesterol levels
JPS57115261A (en) Living body electric regulator for medical treatment
UA9765A (uk) Спосіб нормалізації функціонування органів та систем організму людини цигановой к-м.м.
AU1162788A (en) Oxime-ethers of 2,6-dioxobicyclo-(3.3.0)octanones for treatment of heart and circulation diseases
MX9700148A (es) Dispositivo implantable que contiene celulas de tumor para el tratamiento del cancer.
ES499967A0 (es) Un dispositivo de tratamiento corporal electromagnetico parala modificacion quirurgicamente no invasiva del comporta- miento de desarrollo,reparacion y mantenimiento de celulas ytejidos vivos
ITBO940254A0 (it) Metodo per il miglioramento di alcune funzionalita' del corpo umano.
EP0278715A3 (en) Use of human gamma interferon for treatment of basal cell carcinoma
ATE18989T1 (de) Fixierung von herzklappen-implantatgewebe unter niederdruck.
IT8309425A0 (it) Rivestimento biocompatibile per protesi impiantabili nel corpo umano e procedimento per ottenerlo
IT1245368B (it) Composto ad attivita' calcioantagonista
AU126541S (en) An attachment for a medical examination couch